Literature DB >> 21239672

Hyaluronan, TSG-6, and inter-α-inhibitor in periprosthetic breast capsules: reduced levels of free hyaluronan and TSG-6 expression in contracted capsules.

Kian T Tan1, Andrew D Baildam, Ali Juma, Caroline M Milner, Anthony J Day, Ardeshir Bayat.   

Abstract

BACKGROUND: The exact mechanism of capsular contracture (CC) is still unknown. The covalent modification of hyaluronan (HA) with the heavy chains (HC) of inter-α-inhibitor (IαI) has been identified as an important pathway in inflammation and tissue remodeling, where HC·HA formation is catalyzed by TSG-6 (the protein product of tumor necrosis factor stimulated gene-6).
OBJECTIVE: The authors quantitatively assess the correlation between severity of CC (measured by Baker grade) and expression of HA, TSG-6, and IαI (ie, the polypeptides HC1, HC2, and bikunin) in periprosthetic breast capsules.
METHODS: Immunofluorescent staining for HA, TSG-6, HC1, HC2, and bikunin was carried out on periprosthetic breast capsules (n = 7) of each Baker grade from four anatomical locations. Quantitative analysis was performed to identify differences in staining intensity. Real-time quantitative polymerase chain reaction (RT-qPCR) was performed to determine differences in TSG-6 gene expression levels.
RESULTS: Severity of contracture was associated with reduced staining for both free HA (Pearson correlation coefficient, r = -0.645, P < .001) and TSG-6 (r = -0.642, P = .002). RT-qPCR showed a significant negative correlation between severity of contracture and TSG-6 gene expression levels (r = -0.750, P = .001).
CONCLUSIONS: The negative correlation between TSG-6 expression levels and severity of CC suggests a possible protective role for TSG-6 in the context of CC formation, and this may have a clinically relevant role in prevention of breast CC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239672      PMCID: PMC3428900          DOI: 10.1177/1090820X10391778

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  26 in total

1.  Breast implant capsule with synovial metaplasia.

Authors:  Liron Pantanowitz; Karoly Balogh
Journal:  Breast J       Date:  2003 Sep-Oct       Impact factor: 2.431

2.  Hyaluronan cross-linking: a protective mechanism in inflammation?

Authors:  Anthony J Day; Carol A de la Motte
Journal:  Trends Immunol       Date:  2005-10-07       Impact factor: 16.687

3.  Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice.

Authors:  Csaba Fülöp; Sándor Szántó; Durba Mukhopadhyay; Tamás Bárdos; Rajesh V Kamath; Marylin S Rugg; Anthony J Day; Antonietta Salustri; Vincent C Hascall; Tibor T Glant; Katalin Mikecz
Journal:  Development       Date:  2003-05       Impact factor: 6.868

4.  Up-regulation and differential expression of the hyaluronan-binding protein TSG-6 in cartilage and synovium in rheumatoid arthritis and osteoarthritis.

Authors:  M T Bayliss; S L Howat; J Dudhia; J M Murphy; F P Barry; J C Edwards; A J Day
Journal:  Osteoarthritis Cartilage       Date:  2001-01       Impact factor: 6.576

5.  Biochemical characterization and function of complexes formed by hyaluronan and the heavy chains of inter-alpha-inhibitor (HC*HA) purified from extracts of human amniotic membrane.

Authors:  Hua He; Wei Li; David Y Tseng; Shan Zhang; Szu-Yu Chen; Anthony J Day; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

6.  Superficial zone chondrocytes in normal and osteoarthritic human articular cartilages synthesize novel truncated forms of inter-alpha-trypsin inhibitor heavy chains which are attached to a chondroitin sulfate proteoglycan other than bikunin.

Authors:  Y Yoshihara; A Plaas; B Osborn; A Margulis; F Nelson; M Stewart; M S Rugg; C M Milner; A J Day; K Nemoto; J D Sandy
Journal:  Osteoarthritis Cartilage       Date:  2008-06-03       Impact factor: 6.576

7.  Matrix metalloproteinases, tissue inhibitors of metalloproteinases, aminoterminal propeptide of procollagen type III, and hyaluronan in sera and tissue of patients with capsular contracture after augmentation with Trilucent breast implants.

Authors:  Dietmar Ulrich; Franziska Lichtenegger; Markus Eblenkamp; Dimitrios Repper; Norbert Pallua
Journal:  Plast Reconstr Surg       Date:  2004-07       Impact factor: 4.730

8.  Molecular heterogeneity of the SHAP-hyaluronan complex. Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis.

Authors:  Wannarat Yingsung; Lisheng Zhuo; Matthias Morgelin; Masahiko Yoneda; Daihei Kida; Hideto Watanabe; Naoki Ishiguro; Hisashi Iwata; Koji Kimata
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

Review 9.  TSG-6: a pluripotent inflammatory mediator?

Authors:  C M Milner; V A Higman; A J Day
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

10.  A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44.

Authors:  T H Lee; H G Wisniewski; J Vilcek
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  9 in total

1.  Acute and temporal expression of tumor necrosis factor (TNF)-α-stimulated gene 6 product, TSG6, in mesenchymal stem cells creates microenvironments required for their successful transplantation into muscle tissue.

Authors:  Shigeko Torihashi; Mioko Ho; Yuji Kawakubo; Kazumi Komatsu; Masataka Nagai; Yuri Hirayama; Yuka Kawabata; Nana Takenaka-Ninagawa; Orawan Wanachewin; Lisheng Zhuo; Koji Kimata
Journal:  J Biol Chem       Date:  2015-07-15       Impact factor: 5.157

2.  Capsular Contracture in Breast Implant Surgery: Where Are We Now and Where Are We Going?

Authors:  Yara Bachour
Journal:  Aesthetic Plast Surg       Date:  2021-02-08       Impact factor: 2.326

3.  Histologic, Molecular, and Clinical Evaluation of Explanted Breast Prostheses, Capsules, and Acellular Dermal Matrices for Bacteria.

Authors:  Louis Poppler; Justin Cohen; Utku Can Dolen; Andrew E Schriefer; Marissa M Tenenbaum; Corey Deeken; Richard A Chole; Terence M Myckatyn
Journal:  Aesthet Surg J       Date:  2015-08       Impact factor: 4.283

4.  Serum Inter-α-inhibitor activates the Yes tyrosine kinase and YAP/TEAD transcriptional complex in mouse embryonic stem cells.

Authors:  Sara Pijuan-Galitó; Christoffer Tamm; Cecilia Annerén
Journal:  J Biol Chem       Date:  2014-10-09       Impact factor: 5.157

5.  Constitutive expression of inter-α-inhibitor (IαI) family proteins and tumor necrosis factor-stimulated gene-6 (TSG-6) by human amniotic membrane epithelial and stromal cells supporting formation of the heavy chain-hyaluronan (HC-HA) complex.

Authors:  Suzhen Zhang; Hua He; Anthony J Day; Scheffer C G Tseng
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

6.  Follistatin and the Breast Implant Capsule.

Authors:  Brett A Frenkiel; Peter Temple-Smith; David de Kretser; Graeme J Southwick
Journal:  Plast Reconstr Surg Glob Open       Date:  2017-03-01

7.  PCR Characterization of Microbiota on Contracted and Non-Contracted Breast Capsules.

Authors:  Yara Bachour; Linda Poort; Stephan P Verweij; Gijs van Selms; Hay A H Winters; Marco J P F Ritt; Frank B Niessen; Andries E Budding
Journal:  Aesthetic Plast Surg       Date:  2019-05-02       Impact factor: 2.326

8.  Toll-Like Receptors (TLRs) Expression in Contracted Capsules Compared to Uncontracted Capsules.

Authors:  Y Bachour; M J P F Ritt; R Heijmans; F B Niessen; S P Verweij
Journal:  Aesthetic Plast Surg       Date:  2019-04-01       Impact factor: 2.326

9.  Reduced hyaluronan cross-linking induces breast cancer malignancy in a CAF-dependent manner.

Authors:  Guoliang Zhang; Yiqing He; Yiwen Liu; Yan Du; Cuixia Yang; Feng Gao
Journal:  Cell Death Dis       Date:  2021-06-07       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.